Tokyo, Jan. 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060319) titled 'Effect of very low dose of caffeine on sprint performance' on Jan. 10.
Study Type:
Interventional
Study Design:
Basic Design - Cross-over
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Placebo
Primary Sponsor:
Institute - Ritsumeikan University
Condition:
Condition - Not applicable (sprint performance in healthy track-and-field athletes)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To examine the acute effects of a very low dose of caffeine (1 mg/kg) on sprint running performance and reaction time at the start in athletic sprinters
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Capsulated caffeine or placebo (maltitol) at 1 mg/kg is acutely consumed 1 h before sprint running.
Caffeine condition -> at least 48-h wash-out period -> placebo condition
Interventions/Control_2 - Capsulated caffeine or placebo (maltitol) at 1 mg/kg is acutely consumed 1 h before sprint running.
Placebo condition -> at least 48-h wash-out period -> caffeine condition
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male
Key inclusion criteria - Sprinters, hurdlers, or jumpers engaged in at least 2 hours of daily training for 5 days per week.
Athletes who can complete all-out sprint running.
Key exclusion criteria - An injury making it difficult to perform sprint running;
A mental disorder or cardiovascular disease;
Smoking within the past year;
An allergy to caffeine or the prescribed diet
Target Size - 15
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2023 Year 05 Month 19 Day
Date of IRB - 2023 Year 08 Month 23 Day
Anticipated trial start date - 2023 Year 08 Month 23 Day
Last follow-up date - 2026 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068998
Disclaimer: Curated by HT Syndication.
